Tadalafil and Sildenafil ( DrugBank: Sildenafil, Tadalafil )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
113	筋ジストロフィー	2

113. 筋ジストロフィー

臨床試験数 : 646 / 薬物数 : 471 - (DrugBank : 105) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 170

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01580501 (ClinicalTrials.gov)	March 2012	17/4/2012	PDE Inhibitors in DMD Study (Acute Dosing Study)	Functional Muscle Ischemia and PDE5 Inhibition in Duchenne Muscular Dystrophy: Acute Dosing Study	Duchenne Muscular Dystrophy	Drug: Tadalafil and Sildenafil	Cedars-Sinai Medical Center	NULL	Completed	7 Years	15 Years	Male	12	Phase 1	United States
2	NCT01359670 (ClinicalTrials.gov)	May 2011	23/5/2011	Tadalafil and Sildenafil for Duchenne Muscular Dystrophy	Functional Muscle Ischemia and PDE5A Inhibition in Duchenne Muscular Dystrophy	Duchenne Muscular Dystrophy	Drug: Tadalafil;Drug: Sildenafil	Cedars-Sinai Medical Center	Parent Project Muscular Dystrophy	Completed	7 Years	15 Years	Male	30	Early Phase 1	United States

First Previous1Next Last